Skip to content

Jyong Biotech Ltd.

MENS

CIK 0001954488

← back to feed
Revenue (TTM)
—
FY Dec 2025
Net Income (TTM)
−$4.67M
−54.7% YoY FY Dec 2025
EPS Diluted (TTM)
−$0.06
−50.0% YoY FY Dec 2025
Gross Margin
—
FY Dec 2025
Operating Margin
—
FY Dec 2025
Net Margin
—
FY Dec 2025
Free Cash Flow (TTM)
—
FY Dec 2025
Cash
$1.18M
FY Dec 2025
Total Debt
$17.46M
FY Dec 2025
Shares Outstanding
76.03M sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings